NATURE
Chiricahua just became America's newest national park.
A new name for a landscape protected since 1924.
SOURCEU.S. Department of the Interior
—
ALL THE SLOP
Every serving. No expiration date. Page 2 of 7.
NATURE
A primate lost to science for nearly a century is still alive.
Local rescuers documented more than 90 Bangka slow lorises—and returned 86 to protected forest.
SOURCERe:wild / Alobi Wildlife Rescue Center
—
SCIENCE
The FDA approved the first antisense treatment for chronic Hepatitis B.
In trials, 24% met treatment-stopping criteria versus none on placebo; 19% stayed controlled 24 weeks after stopping all therapy.
SOURCEU.S. Food and Drug Administration
—
HUMANS
Six online sessions cut reported campus sexual aggression odds 73%.
A prevention program built for men paired consent, empathy, alcohol-risk awareness, and bystander practice.
SOURCEReasons to be Cheerful / RealConsent randomized trial
—
SCIENCE
FDA approved an immunotherapy that may let some rectal-cancer patients skip surgery.
In an ongoing trial, nearly three-quarters had not needed the usual treatments after a median of more than two years.
SOURCEU.S. Food and Drug Administration
—
SCIENCE
A year of step data flagged future brain-health risk.
The long pattern—not one day's reading—may help clinicians spot who needs earlier attention.
SOURCEAmerican Neurological Association / Newswise
—
NATURE
Bristol added two more floating ecosystems to its harbour.
Native plants now shelter fish, pollinators and nesting birds in the middle of the city.
SOURCEWest of England Mayoral Combined Authority / Bristol City Council
—
SCIENCE
One health system cut anesthetic emissions 45%—and spending nearly 40%.
Six hospitals changed everyday anesthesia practice, lowering estimated emissions and anesthetic spending without worsening tracked outcomes.
SOURCEAmerican Society of Anesthesiologists
—
NATURE
Bleached corals came back to full health in seven weeks.
A brief tissue bridge moved helpful algae within three days—and recovery continued after the corals were separated.
SOURCEStanford Doerr School of Sustainability / Science Advances
—
SCIENCE
Roman's main camera is seeing nearly 30% sharper than expected.
NASA's newly launched space telescope has cleared an early commissioning test with more optical precision than its requirement demanded.
SOURCENASA
—
ANIMALS
Fifteen frogs the size of a pencil tip just made history.
The first Afia Birago's puddle frogs ever born under human care are now hopping at London Zoo.
SOURCELondon Zoo (ZSL)
—
SCIENCE
A major Alzheimer's prevention trial has randomized its first participant.
The study will test whether clearing amyloid, then adding a second mechanism, can delay inherited Alzheimer's.
SOURCEBanner Health
—
NATURE
Nine funders just put more than $500 million behind species recovery.
A new alliance is coordinating five years of targeted recovery funding.
SOURCERe:wild
—
SCIENCE
EU regulators backed a new pancreatic-cancer pill.
An EMA committee recommended a once-daily oral RAS inhibitor for eligible adults with metastatic pancreatic cancer.
SOURCEEuropean Medicines Agency
—
SCIENCE
Ghana cut malaria deaths 98%.
Reported malaria deaths fell from 3,259 in 2011 to 52 in 2025.
SOURCEGhana Health Service
—
SCIENCE
A tiny sensor gave people with type 2 diabetes five more hours in range.
A randomized trial found continuous glucose monitoring added about five hours a day in the target range—even without insulin.
SOURCENew England Journal of Medicine
—
NATURE
The world's rarest ape has grown to 44.
Forty-four, from the brink.
SOURCEHainan International Media Center
—
SCIENCE
Vaccines prevented 2.2 million future deaths in one year.
The future changed 2.2 million times.
SOURCEGavi, the Vaccine Alliance
—
SCIENCE
A Swedish CAR-T trial saw complete responses in 8 of 12 patients.
Eight complete responses. Twelve patients.
SOURCEElicera Therapeutics
—
SCIENCE
Patient feedback cut an epilepsy monitor’s false alarms by about 80%.
A monitor improved when patients could explain what its sensors got wrong.
SOURCENational Institutes of Health / Nature Medicine
—
SCIENCE
An experimental drug shielded celiac patients during a gluten challenge.
A 32-person study found less injury and fewer symptoms—but it is still early.
SOURCEReuters / AnaptysBio
—
SCIENCE
A rare-disease drug reported zero new bone lesions through 84 weeks.
In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.
SOURCERegeneron / The Lancet
—
SCIENCE
River blindness transmission is gone from 11 of 13 Americas foci.
A new WHO review says transmission now remains only in the remote cross-border Yanomami Focus Area shared by Brazil and Venezuela.
SOURCEWorld Health Organization
—
SCIENCE
Taiwan reached a 92.7% Hepatitis C treatment rate.
More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.
SOURCECommercial Times (Taiwan)
—